GDRX:NSD-Goodrx Holdings Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 7.75

Change

+0.03 (+0.39)%

Market Cap

USD 2.93B

Volume

0.82M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

+0.15 (+0.17%)

USD 38.86B
HQY HealthEquity Inc

+0.55 (+0.70%)

USD 6.83B
RCM R1 RCM Inc

-0.02 (-0.14%)

USD 5.96B
BTSG BrightSpring Health Services, ..

+0.72 (+5.17%)

USD 2.37B
PRVA Privia Health Group Inc

+0.11 (+0.59%)

USD 2.23B
PINC Premier Inc

-0.23 (-1.11%)

USD 2.03B
OMCL Omnicell Inc

+0.05 (+0.11%)

USD 1.99B
CERT Certara Inc

+0.13 (+1.21%)

USD 1.76B
SDGR Schrodinger Inc

-0.24 (-1.21%)

USD 1.48B
MDRX Veradigm Inc.

-0.15 (-1.52%)

USD 1.04B

ETFs Containing GDRX

UKDV:LSE SPDR S&P UK Dividend Aris.. 4.96 % 0.00 %

+0.03 (+2.48%)

USD 0.10B
SPYG:XETRA SPDR S&P UK Dividend Aris.. 4.96 % 0.00 %

N/A

USD 0.11B
UKDV:SW SPDR® S&P UK Dividend Ar.. 4.96 % 0.00 %

+0.01 (+2.48%)

USD 0.11B
ELEC:LSE 4.64 % 0.00 %

N/A

N/A
ELEP:LSE 4.64 % 0.00 %

N/A

N/A
RNRG:LSE Global X Renewable Energy.. 3.97 % 0.00 %

+0.02 (+2.48%)

USD 3.49M
ELEC:XETRA 3.94 % 0.00 %

N/A

N/A
HCLN:CA Harvest Clean Energy ETF .. 2.91 % 0.00 %

+0.07 (+2.48%)

CAD 0.02B
FNRG:LSE Fidelity Clean Energy UCI.. 2.64 % 0.00 %

+0.06 (+2.48%)

USD 0.01B
FCIV:CA Fidelity International Va.. 2.39 % 0.00 %

-0.09 (2.48%)

CAD 0.25B
VXM-B:CA CI Morningstar Internatio.. 0.63 % 0.00 %

N/A

CAD 0.29B
AVDV Avantis® International S.. 0.59 % 0.00 %

-0.16 (2.48%)

USD 6.55B
FDTS First Trust Developed Mar.. 0.56 % 0.80 %

+0.10 (+2.48%)

USD 8.42M
VXM:CA First Asset Morningstar I.. 0.00 % 0.70 %

+0.59 (+2.48%)

CAD 0.01B
SPYG:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.67% 77% C+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.67% 77% C+ 75% C
Trailing 12 Months  
Capital Gain 29.17% 85% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.17% 83% B 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -20.25% 38% F 17% F
Dividend Return -20.25% 38% F 17% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.12% 60% D- 44% F
Risk Adjusted Return -49.24% 40% F 18% F
Market Capitalization 2.93B 93% A 84% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.